Conferences

Trending

All conferences

ACC 2021: Findings from the RAFT-AF Trial

Anthony SL Tang

Watch time: 15m 16s
Phase I Results from the Solve-CRT Study | cardiac resynchronization therapy

Jagmeet P Singh

Watch time: 5m 52s
View from the Thoraxcenter – What's Hot at ESC 2021

Joost Daemen, Nicolas M Van Mieghem

Watch time: 25m 18s
ESC 2021 Discussion: The EMPEROR-Preserved Trial

Stefan Anker, Harriette Van Spall

Watch time: 19m 47s
ESC 2021 Discussion: The EMPEROR-Pooled Study

Milton Packer, Harriette Van Spall

Watch time: 20m 8s
View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem

Watch time: 36m 1s
MANAGE-HF: Remote Data May Help Reduce Adverse Events

Larry A Allen

Watch time: 8m 35s
Redwood-HCM: Second-Generation Drug for HCM Well-Tolerated by Patients

Martin S Maron

Watch time: 7m 16s
GALACTIC-HF Subgroup Analysis: Omecamtiv Mecarbil Effective Across Ethnic Groups

David Lanfear

Watch time: 5m 27s
AHA 21: Results From Rose Clinical Trial CETPi Lowers LDL-C in Patients Taking High Intensity Statins

Stephen Nicholls

Watch time: 5m 41s
EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFpEF

Javed Butler

Watch time: 6m 35s
AHA 2021 Late-breaker Discussion: The EMPULSE Trial

Harriette Van Spall, Adriaan A Voors

Watch time: 16m 38s